Life-Saving Machine Receives Funding from Federal Government
The federal government of Australia has approved a funding boost of $1 million for the development of a life-saving machine that would act as a replacement for heart and lungs in case of organ failure. The research for this device includes the advanced tech Extracorporeal Membrane Oxygenation (ECMO) machine. Specifically, this machine is effective in the simulation of heart and lung bypass in case of any organ failure due to heart or lung failure.
Moreover, this newly funded Ecmo machine has been developed using the precise study that is led by Dr Aidan from Monash University, who had collaborated with Alfred Health at St Vincent's Hospital in Syndey, the University of Sydney and the Critical Care research group from the University of Queensland.
According to Dr Burrel, "This new funding will allow us to investigate whether biomarkers can better identify which patients will derive the best long-term benefit from ECMO, potentially leading to more targeted ECMO support and improved patient care."
In the meantime, PRECISE will study 236 patients to learn about the long terms benefits of using the ECMO machine. The study is combined with the National ECMO Registry (EXCEL Registry), which is led by Professor Carol Hodgson, the Head of clinical trials and cohort studies.
Source
Monash University
